Oliver Lagore Vanvalin Investment Group’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-90
Closed -$11.2K 722
2024
Q3
$11.2K Hold
90
﹤0.01% 407
2024
Q2
$14.2K Hold
90
﹤0.01% 374
2024
Q1
$11.7K Hold
90
﹤0.01% 394
2023
Q4
$8.68K Sell
90
-7
-7% -$675 ﹤0.01% 433
2023
Q3
$11.8K Buy
97
+7
+8% +$849 ﹤0.01% 410
2023
Q2
$10.3K Hold
90
﹤0.01% 454
2023
Q1
$12.4K Hold
90
0.01% 355
2022
Q4
$11.7K Hold
90
0.01% 342
2022
Q3
$10K Hold
90
0.01% 342
2022
Q2
$7K Hold
90
﹤0.01% 380
2022
Q1
$7K Buy
+90
New +$7K ﹤0.01% 381